Literature DB >> 3628796

Nonpalpable lesions detected with mammography: review of 512 consecutive cases.

S Ciatto, L Cataliotti, V Distante.   

Abstract

The authors reviewed 512 consecutive cases in which biopsies were performed on nonpalpable lesions of the breast detected with mammography from 1970 to 1985. The positive predictive value (PPV) of different radiologic patterns was determined. Biopsy is advised in the presence of patterns such as parenchymal distortion, opacities with undefined borders, strongly suspect microcalcifications (rodlike or branching morphologic features, high spatial density), and stellate opacities, which yielded higher PPVs (0.11, 0.35, 0.56, and 0.75, respectively). The average detection rate of preclinical cancer was 0.7 per 1,000; wide variations were recorded during different periods in the study (0.2 per 1,000 and 1.3 per 1,000 in the first 4 years and the last 4 years of the study, respectively), for the different age groups considered (0.6 per 1,000 and 1.7 per 1,000 for the 30-39-year and over-59-year age groups, respectively), and for different reporting radiologists (0.5-1.9 per 1,000). The ratio of benign to malignant biopsy findings was 2.4:1 for the whole series, with wide variations encountered relative to the variables mentioned above.

Entities:  

Mesh:

Year:  1987        PMID: 3628796     DOI: 10.1148/radiology.165.1.3628796

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  Breast biopsy rate and positivity in Rhode Island.

Authors:  M S Richards; J Feldman; R A Smith; B A DeBuono
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

2.  The mammographic density of a mass is a significant predictor of breast cancer.

Authors:  Ryan W Woods; Gale S Sisney; Lonie R Salkowski; Kazuhiko Shinki; Yunzhi Lin; Elizabeth S Burnside
Journal:  Radiology       Date:  2010-12-21       Impact factor: 11.105

3.  Vacuum-assisted biopsy diagnosis of atypical ductal hyperplasia and patient management.

Authors:  A Ancona; M Capodieci; A Galiano; F Mangieri; V Lorusso; G Gatta
Journal:  Radiol Med       Date:  2011-01-12       Impact factor: 3.469

4.  Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging.

Authors:  H Palmedo; F Grünwald; H Bender; A Schomburg; P Mallmann; D Krebs; H J Biersack
Journal:  Eur J Nucl Med       Date:  1996-08

5.  A clinical algorithm for the management of abnormal mammograms. A community hospital's experience.

Authors:  D Gist; J Llorente; J Mayer
Journal:  West J Med       Date:  1997-01

6.  Stereotactic vacuum-assisted breast biopsy in 268 nonpalpable lesions.

Authors:  M Tonegutti; V Girardi
Journal:  Radiol Med       Date:  2008-02-25       Impact factor: 3.469

7.  Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities.

Authors:  G M Fuhrman; G J Cederbom; J S Bolton; T A King; J L Duncan; J L Champaign; D H Smetherman; G H Farr; R R Kuske; W M McKinnon
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

8.  Positive predictive value of specific mammographic findings according to reader and patient variables.

Authors:  Aruna Venkatesan; Philip Chu; Karla Kerlikowske; Edward A Sickles; Rebecca Smith-Bindman
Journal:  Radiology       Date:  2009-01-21       Impact factor: 11.105

9.  Detectability and Usefulness of Automated Whole Breast Ultrasound in Patients with Suspicious Microcalcifications on Mammography: Comparison with Handheld Breast Ultrasound.

Authors:  Jae Jeong Choi; Sung Hun Kim; Bong Joo Kang; Byung Joo Song
Journal:  J Breast Cancer       Date:  2016-12-23       Impact factor: 3.588

10.  Validation of results from knowledge discovery: mass density as a predictor of breast cancer.

Authors:  Ryan W Woods; Louis Oliphant; Kazuhiko Shinki; David Page; Jude Shavlik; Elizabeth Burnside
Journal:  J Digit Imaging       Date:  2009-09-16       Impact factor: 4.056

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.